Drug intelligence / Profile preview

Renzhu Jianwei granules

Development stage
Unknown
Lead developer
Nanjing Zhongshan Pharmaceutical
Administration
Oral
01

Overview

Renzhu Jianwei granules (also known as Renzhu Jianwei Granula or RJG) is a traditional Chinese medicine (TCM) compound originally developed as an in-hospital preparation by the Jiangsu Provincial Hospital of Traditional Chinese Medicine (Affiliated Hospital of Nanjing University of Chinese Medicine) based on the clinical experience of the renowned TCM physician Shan Zhaowei. The formulation consists of eight herbal ingredients: *Astragali radix* (Huangqi), *Atractylodis macrocephalae rhizoma* (Baizhu), *Coicis semen* (Yiyiren), *Scutellariae radix* (Huangqin), *Agrimoniae herba* (Xianhecao), *Curcumae rhizoma* (Ezhu), *Lobeliae chinensis herba* (Banbianlian), and *Scleromitrion diffusum herba* (Banzhilian). It is designed to nourish the spleen and stomach, replenish qi, invigorate blood, and clear heat. Renzhu Jianwei granules are primarily developed for the treatment of chronic atrophic gastritis (CAG) and gastric precancerous lesions (such as severe intestinal metaplasia or dysplasia). Nanjing Zhongshan Pharmaceutical has developed the compound as a Class 1.1 TCM new drug and submitted a marketing application (NDA) in China in late 2024.

Other names
Renzhu Jianwei GranulaRenzhu Jianwei granuleRenzhu Jianwei KeliRJG仁术健胃颗粒

Beyond the preview

Go deeper on Renzhu Jianwei granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renzhu Jianwei granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call